Trial Search Results

Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy

We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent maternal and neonatal complications of hyperglycemia.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Device: Dexcom Seven Plus Continuous Glucose Monitoring System

Eligibility


Inclusion Criteria:- 18 years of age or older

   - Receiving betamethasone as part of routine clinical care.

   - Pregnancy between 23+5 and 35+0 weeks

Exclusion Criteria:- Less than 18 years old.

   - Major fetal anomalies

   - Use of steroid medications in the past 2 weeks.

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Yasser El-Sayed
6507233198
Not Recruiting